These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 1384898)
1. Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model. Callaway JB; Smith SA; Widman DG; McKinnon KP; Scholle F; Sempowski GD; Dittmer DP; Crowe JE; de Silva AM; Ting JP PLoS One; 2015; 10(8):e0136708. PubMed ID: 26301593 [TBL] [Abstract][Full Text] [Related]
2. Preserved in vivo reconstitution ability of PBSCs cryopreserved for a decade at -80 °C. Shima T; Iwasaki H; Yamauchi T; Kadowaki M; Kiyosuke M; Mochimaru T; Takenaka K; Miyamoto T; Akashi K; Teshima T Bone Marrow Transplant; 2015 Sep; 50(9):1195-200. PubMed ID: 26098951 [TBL] [Abstract][Full Text] [Related]
3. Mobilization of Peripheral Blood Stem Cells Using Regimen Combining Docetaxel with Granulocyte Colony-stimulating Factor in Breast Cancer Patients. Yu J; Ren J; Di LJ; Song GH; Zhu YL; Zhang J; Liang X; Che L; Jiang HF; Jia J; Zhang CR Chin J Cancer Res; 2011 Mar; 23(1):49-53. PubMed ID: 23467566 [TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial comparing granulocyte-colony-stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation. Renfroe H; Arnold M; Vaughn L; Harvey RD; Hamilton E; Lonial S; Khoury HJ; Kaufman JL; Lechowicz MJ; Flowers CR; Waller EK Transfusion; 2011 Aug; 51(8):1779-83. PubMed ID: 21332729 [TBL] [Abstract][Full Text] [Related]
5. Virus reactivation in high-risk non-Hodgkin's lymphoma patients after autologous CD34+ -selected peripheral blood progenitor cell transplantation. Lin PC; Lee MY; Lin JT; Hsiao LT; Chen PM; Chiou TJ Int J Hematol; 2008 May; 87(4):434-439. PubMed ID: 18317882 [TBL] [Abstract][Full Text] [Related]
6. Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy. Ueda Y; Itoh T; Fuji N; Harada S; Fujiki H; Shimizu K; Shiozaki A; Iwamoto A; Shimizu T; Mazda O; Kimura T; Sonoda Y; Taniwaki M; Yamagishi H Cancer Immunol Immunother; 2007 Mar; 56(3):381-9. PubMed ID: 16830156 [TBL] [Abstract][Full Text] [Related]
7. Influential factors for the collection of peripheral blood stem cells and engraftment in acute myeloid leukemia patients in first complete remission. Lee J; Lee MH; Park KW; Kang JH; Im DH; Kim K; Lee SH; Kim WS; Park J; Jung CW; Parka K Int J Hematol; 2005 Apr; 81(3):258-63. PubMed ID: 15814338 [TBL] [Abstract][Full Text] [Related]
8. Storage of noncryopreserved periphered blood stem cells for transplantation. Hechler G; Weide R; Heymanns J; Köppler H; Havemann K Ann Hematol; 1996 May; 72(5):303-6. PubMed ID: 8645742 [TBL] [Abstract][Full Text] [Related]
9. Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product. Dreger P; Marquardt P; Haferlach T; Jacobs S; Mülverstedt T; Eckstein V; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N Br J Cancer; 1993 Nov; 68(5):950-7. PubMed ID: 7692921 [TBL] [Abstract][Full Text] [Related]
10. Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings. Frampton JE; Yarker YE; Goa KL Drugs; 1995 May; 49(5):767-93. PubMed ID: 7541335 [TBL] [Abstract][Full Text] [Related]
11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
12. [Collection of hematopoietic progenitor cells from healthy donors]. Bojanić I; Cepulić BG; Mazić S Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352 [TBL] [Abstract][Full Text] [Related]
13. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells . Haas R; Murea S Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Teshima T; Harada M; Takamatsu Y; Makino K; Taniguchi S; Inaba S; Kondo S; Tanaka T; Akashi K; Minamishima I Bone Marrow Transplant; 1992 Sep; 10(3):215-20. PubMed ID: 1384898 [TBL] [Abstract][Full Text] [Related]
15. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children. Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells. Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688 [TBL] [Abstract][Full Text] [Related]